**Question:** The following drugs are used for the treatment of type II lepra reaction, except –

A. Dapsone
B. Methylene blue
C. Streptomycin
D. Clofazimine

**Correct Answer:** C. Streptomycin

**Core Concept:**
Type II leprosy reaction is a severe complication of leprosy characterized by intense inflammation, pain, and tissue damage. It is also known as erythema nodosum leprosum (ENL). Treatment options for type II leprosy reactions include corticosteroids, antibiotics, and immunomodulatory agents.

**Why the Correct Answer is Right:**
Streptomycin is primarily used as a first-line antibiotic for the treatment of Mycobacterium leprae and Mycobacterium lepromatosis infections, the causative agents of leprosy. Although it has immunomodulatory effects, its primary role is as an antimicrobial agent. In contrast, the other drugs listed are specifically used for the treatment of type II leprosy reactions due to their immunomodulatory properties.

**Why Each Wrong Option is Incorrect:**
A. Dapsone: A sulfonamide antibiotic, dapsone has immunomodulatory effects that help in controlling type II leprosy reactions.
B. Methylene blue: Although methylene blue has been used as an adjuvant therapy for ENL, its primary use is as a dye, not specifically for treating leprosy-related complications.
D. Clofazimine: Clofazimine is a lipophilic antituberculosis drug primarily used in multidrug therapy (MDT) for leprosy. It has immunomodulatory effects, making it suitable for treating type II leprosy reactions.

**Clinical Pearl:**
Clinicians should be aware of the specific role of each drug mentioned in the question when managing patients with type II leprosy reactions. A tailored treatment approach based on the underlying mechanism helps in effectively managing these complications.

In conclusion, while streptomycin is essential for the treatment of leprosy itself, it is not specifically used for treating type II leprosy reactions due to the primary focus on antimicrobial properties. On the other hand, dapsone, clofazimine, and methylene blue have proven efficacy in managing type II leprosy reactions due to their immunomodulatory effects.